Accelerate Your Oncology Breakthroughs With Veristat

Oncology clinical trials are inherently complex, requiring deep scientific understanding, strategic planning, and operational excellence. Veristat specializes in accelerating oncology drug development by addressing these challenges with a science-first approach and comprehensive trial support. Veristat services include designing adaptive, patient-centric trial protocols, implementing initiatives like Project FrontRunner, and optimizing data collection to reduce patient burden. Our statistical and regulatory teams ensure trials are robust and compliant, while our clinical operations support biomarker-driven strategies with efficient genomic testing and data analysis.

Veristat’s impact is demonstrated through case studies, including an on-time IND approval for a novel therapy, early advancement of a Phase II pancreatic cancer trial, and FDA/EMA approval for an ultra-rare blood cancer treatment. From regulatory strategy to full-service trial execution, Veristat partners with sponsors to streamline oncology development and accelerate access to life-saving therapies.